European journal of ophthalmology, cilt.21, sa.2, ss.156-61, 2011 (SCI-Expanded, Scopus)
PURPOSE. To investigate the inflammation of the anterior chamber after intravitreal bevacizumab injection in different ocular exudative diseases.